-
The company offers test for markers for cancer treatment for both lung and colon cancer to help determine which treatment plans will benefit the patient. The use of genetic testing is getting very specific as well as the tests and expressions. “RGI has determined ranges of ERCC1 expression...
-
Tests to detect cancer of the unknown primary Rosetta Genomics – Today I had the opportunity to speak with and interview Ronen Tamir, Chief Commercialization Officer, at Rosetta to find out how microRNA is helping diagnose and treat cancer. If you have been keeping up with the news of late...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-08-2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests
-
Earlier this year a collaboration effort was established with the NIH to determine the role of microRNAs in HIV viral replication, and their potential to act as novel drug targets for future therapy, and with the purchase of Parkway Clinical Labs this year, there’s a lot going on here. Stay tuned as...
-
Briefly, the test determines if the PTEN gene is functioning properly, as it is a tumor suppressor gene that is linked with cell regulation. If patients have a low level of the protein, studies have shown a progression of the cancer, while if the levels remain higher, the less chances of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, tumors, Chemotherapy, markers, PTEN gene, Myriad, diagnositic tests
-
A piano player gives up his job, goes to medical school and now has and R and D project with clinical trials for brain cancer. He also works with Microsoft co-founder Paul Allen's Allen Brain Institute who has healthy brain statistical information compiled for comparison. The research involves...
-
It keeps getting smarter out there, and this looks to be something that I hope moves along very quickly, so instead of waiting days or weeks for blood tests, this could be done at bedside at the hospital, or for that matter even at the office perhaps down the road. BD When you're sick, getting...
-
10 genetic mutations were found in the patient's tumor and virtually every cell in the tumor sample had nine of the mutations. “What's striking about the new research is that the scientists were able to sift through the 3 billion pairs of chemical bases that make up the human genome to...
-
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
-
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
-
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-13-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
-
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-19-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
-
This is a very small clinical trial of 12 individuals with cancer, and any related treatment plans are still quite a few miles away, but more work with personalized medicine in progress. BD This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment...
-
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-11-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests
-
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-05-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing
-
For those of you who read the blog here and are not aware of what a "Carnival" is, it represents a collection of some of the top blogging posts in a period of time assembled in one place to review and read. Today, Highlight Health is hosting the carnival and I am delighted that...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-05-2008
Filed under:
Filed under: Medically Related, Technology, Genomics, healthcare, Proteins, Cancer, cancer research, Pharmacogenomics, R and D, Bloggers, Stand up to Cancer